Guided Therapeutics, Inc., a medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally. It offers LuViva, an advanced cervical scan non-invasive cervical cancer detection device that provides less invasive and painless alternative to conventional tests for identifying, screening, and detecting cervical cancers and precancers. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.
Frequently asked questions
What sector does Guided Therapeutics Inc (GTHP) operate in?
Guided Therapeutics Inc belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Guided Therapeutics Inc (GTHP) current stock price?
As of the latest data, Guided Therapeutics Inc stock price is $0.25, with a previous close of $0.25.
What is Guided Therapeutics Inc (GTHP) current market capitalization?
Guided Therapeutics Inc market cap is approximately 24.13 million.
What is Guided Therapeutics Inc (GTHP) Earnings Per Share (EPS)?
The trailing EPS is -$0.04.
Does Guided Therapeutics Inc (GTHP) pay dividends?
No. Guided Therapeutics Inc does not pay a dividend.
What is Guided Therapeutics Inc (GTHP) beta (volatility) score?
Guided Therapeutics Inc has a beta of 0.725, indicating lower volatility than the overall market.
